Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Clin Invest
2014 Nov 01;12411:4723-36. doi: 10.1172/JCI76126.
Show Gene links
Show Anatomy links
Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
McCormick JA
,
Yang CL
,
Zhang C
,
Davidge B
,
Blankenstein KI
,
Terker AS
,
Yarbrough B
,
Meermeier NP
,
Park HJ
,
McCully B
,
West M
,
Borschewski A
,
Himmerkus N
,
Bleich M
,
Bachmann S
,
Mutig K
,
Argaiz ER
,
Gamba G
,
Singer JD
,
Ellison DH
.
???displayArticle.abstract???
Familial hyperkalemic hypertension (FHHt) is a monogenic disease resulting from mutations in genes encoding WNK kinases, the ubiquitin scaffold protein cullin 3 (CUL3), or the substrate adaptor kelch-like 3 (KLHL3). Disease-associated CUL3 mutations abrogate WNK kinase degradation in cells, but it is not clear how mutant forms of CUL3 promote WNK stability. Here, we demonstrated that an FHHt-causing CUL3 mutant (CUL3 Δ403-459) not only retains the ability to bind and ubiquitylate WNK kinases and KLHL3 in cells, but is also more heavily neddylated and activated than WT CUL3. In cells, activated CUL3 Δ403-459 depleted KLHL3, preventing WNK degradation, despite increased CUL3-mediated WNK ubiquitylation; therefore, CUL3 loss in kidney should phenocopy FHHt in murine models. As predicted, nephron-specific deletion of Cul3 in mice did increase WNK kinase levels and the abundance of phosphorylated Na-Cl cotransporter (NCC). Over time, however, Cul3 deletion caused renal dysfunction, including hypochloremic alkalosis, diabetes insipidus, and salt-sensitive hypotension, with depletion of sodium potassium chloride cotransporter 2 and aquaporin 2. Moreover, these animals exhibited renal inflammation, fibrosis, and increased cyclin E. These results indicate that FHHt-associated CUL3 Δ403-459 targets KLHL3 for degradation, thereby preventing WNK degradation, whereas general loss of CUL3 activity - while also impairing WNK degradation - has widespread toxic effects in the kidney.
Bostanjoglo,
11Beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules.
1998, Pubmed
Bostanjoglo,
11Beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules.
1998,
Pubmed
Boyden,
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
2012,
Pubmed
Canning,
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.
2013,
Pubmed
Castañeda-Bueno,
Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.
2012,
Pubmed
,
Xenbase
Chávez-Canales,
WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
2014,
Pubmed
,
Xenbase
Galan,
Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism.
1999,
Pubmed
Gamba,
Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter.
1993,
Pubmed
,
Xenbase
Hoorn,
The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension.
2011,
Pubmed
Isobe,
Development of enzyme-linked immunosorbent assays for urinary thiazide-sensitive Na-Cl cotransporter measurement.
2013,
Pubmed
Kossatz,
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells.
2010,
Pubmed
Lalioti,
Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule.
2006,
Pubmed
Louis-Dit-Picard,
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron.
2012,
Pubmed
Mayan,
Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.
2002,
Pubmed
McCormick,
A SPAK isoform switch modulates renal salt transport and blood pressure.
2011,
Pubmed
McEvoy,
Constitutive turnover of cyclin E by Cul3 maintains quiescence.
2007,
Pubmed
Meyer-Schaller,
The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes.
2009,
Pubmed
Ohta,
The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
2013,
Pubmed
Ooi,
CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma.
2013,
Pubmed
Pathare,
A molecular update on pseudohypoaldosteronism type II.
2013,
Pubmed
Pelham,
Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase.
2012,
Pubmed
Piechotta,
Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).
2002,
Pubmed
Reiche,
SORLA/SORL1 functionally interacts with SPAK to control renal activation of Na(+)-K(+)-Cl(-) cotransporter 2.
2010,
Pubmed
Sabath,
Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease.
2004,
Pubmed
,
Xenbase
San-Cristobal,
WNK3 and WNK4 amino-terminal domain defines their effect on the renal Na+-Cl- cotransporter.
2008,
Pubmed
,
Xenbase
Saritas,
SPAK differentially mediates vasopressin effects on sodium cotransporters.
2013,
Pubmed
Schmitt,
Renal expression of sodium transporters and aquaporin-2 in hypothyroid rats.
2003,
Pubmed
Shibata,
Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
2013,
Pubmed
Singer,
Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells.
1999,
Pubmed
Stoessel,
Connexin 37 is localized in renal epithelia and responds to changes in dietary salt intake.
2010,
Pubmed
Susa,
Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
2014,
Pubmed
Traykova-Brauch,
An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice.
2008,
Pubmed
Uchida,
Regulation of with-no-lysine kinase signaling by Kelch-like proteins.
2014,
Pubmed
Vidal-Petiot,
WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.
2013,
Pubmed
Wakabayashi,
Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension.
2013,
Pubmed
Wu,
Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.
2013,
Pubmed
,
Xenbase
Yang,
WNK1 and WNK4 modulate CFTR activity.
2007,
Pubmed
,
Xenbase
Yang,
Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.
2007,
Pubmed
Zagórska,
Regulation of activity and localization of the WNK1 protein kinase by hyperosmotic stress.
2007,
Pubmed
Zhang,
Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway.
2005,
Pubmed
Zhou,
Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases.
1998,
Pubmed
